The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
The NFI is published to promote the rational use of medicines in the country.
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
Cipla has reported consolidated financial results for the period ended September 30, 2021
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
It answers the most basic questions from a patient’s perspective
A total of 12 generic medicines have been included in the list
ANG Lifesciences India Limited has reported financial results for the period ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
